has been acquired by

The Restructuring Group of Capstone Partners Advises an Advanced Molecular Imaging Company

February 2014

Industry:  Consumer Electronics

Challenge:  The company filed for Chapter 11 to preserve the value of the estate. CRS was retained to serve as the investment banker. We conducted the post-petition sales process of both the Debtors’ clinical and pre-clinical divisions.

Solution:  Capstone assembled a list of 58 logical prospective buyers  We reached out to each of these parties to gauge interest in purchasing some or all of the Debtors’ business/assets. CRS prepared and distributed a summary “teaser and Confidential Information Memorandum” (“CIM”) as well as developed and maintained an extensive data room. CRS conducted interviews and negotiated terms with several potential buyers.

Results:  Successfully sold the assets as part of the 363 sales process. All constituents received incremental value due the comprehensive process.